查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589449

皮肤科治疗药物市场：按药物类别、应用分类 - 全球预测 2025-2030

Dermatological Therapeutics Market by Drug Class (Anti-Acne, Anti-Infectives, Calcineurin Inhibitors), Application (Alopecia, Atopic Dermatitis, Herpes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年皮肤科治疗市场价值为569.9亿美元，预计到2024年将达到626.8亿美元，复合年增长率为10.38%，到2030年将达到1137.9亿美元。

皮肤科治疗市场涵盖各种旨在解决皮肤相关健康问题的治疗方法和产品，从痤疮和干癣等常见疾病到黑色素瘤等严重。由于皮肤病的增加、环境变化和生活方式因素刺激的护肤和治疗选择意识的提高，该细分市场是必要的。皮肤科治疗应用包括局部治疗、全身治疗以及生技药品和基因治疗等先进治疗，主要最终用户是医疗中心、皮肤科诊所和研究机构。主要成长要素包括医疗保健支出增加、技术创新增加以及对美容增强手术的强劲需求。个人化医疗和基因研究的兴起为治疗罕见和严重皮肤病开闢了潜在机会，对该领域的投资可以产生丰厚的回报。为了抓住这些机会，公司应专注于需求未满足的新兴市场，并投资于创新药物开发技术。但由于研发成本上升、法规环境严格、学名药竞争等挑战，该药仍有其限制。公司还必须克服与新疗法相关的专利悬崖和潜在副作用。最有希望创新的领域包括生物疗法、远距皮肤病学的进步以及个人化诊断和治疗的人工智慧。市场是动态的，其特点是技术进步和消费者期望驱动的激烈竞争和快速变化。专注于具有治疗和美容功效的多功能药物的研发与满足皮肤健康和美容需求的产品需求相一致，代表了一条增长之路。寻求保持竞争力的公司也应该考虑策略联盟和收购，以加强其产品组合和市场覆盖范围。透过驾驭这些动态，皮肤病治疗市场的相关人员可以利用创新和未满足的临床需求来有效刺激业务成长。

主要市场统计
基准年[2023] 569.9亿美元
预测年份 [2024] 626.8亿美元
预测年份 [2030] 1137.9亿美元
复合年增长率（%） 10.38%

市场动态：揭示快速发展的皮肤科治疗市场的关键市场洞察

供需的动态交互作用正在改变皮肤科治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 皮肤病盛行率增加
    • 医疗费用增加和对皮肤病的认识提高
    • 对同类疗法皮肤病治疗的需求增加
  • 市场限制因素
    • 皮肤科治疗费用比较高
  • 市场机会
    • 开发下一代皮肤癌治疗方法
    • 皮肤科治疗的研究、开发与技术创新
  • 市场问题
    • 某些治疗类别的副作用

波特五力：驾驭皮肤科药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解皮肤科药物市场的外部影响

外部宏观环境因素在塑造皮肤科治疗市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解皮肤科治疗市场的竞争格局

皮肤病治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：皮肤科治疗市场供应商的绩效评估

FPNV定位矩阵是评估皮肤科治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製皮肤病治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，皮肤病治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 市场驱动因素
      • 皮肤病盛行率增加
      • 医疗费用增加和对皮肤病的认识提高
      • 对同类疗法皮肤病治疗的需求增加
    • 抑制因素
      • 皮肤科治疗费用比较高
    • 市场机会
      • 开发下一代皮肤癌治疗方法
      • 皮肤医学研究、开发与技术创新
    • 市场问题
      • 某些治疗类别的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章皮肤科药物市场：依药物类别

  • 介绍
  • 预防痤疮
  • 抗感染
  • Calcineurin抑制剂
  • 皮质类固醇
  • 类视色素A

第七章皮肤科治疗药物市场：依应用分类

  • 介绍
  • 脱髮症
  • 异位性皮肤炎
  • 疱疹
  • 干癣
  • 酒糟样皮肤炎

第八章北美和南美皮肤科药物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太皮肤科药物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲皮肤科药物市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aclaris Therapeutics Inc.
  • Allergan PLC by AbbVie Inc.
  • Almirall, LLC
  • Amgen Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Galderma Laboratories, LP
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services Inc.
  • Leo Pharma A/S
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries, Inc.
Product Code: MRR-742BD517D23A

The Dermatological Therapeutics Market was valued at USD 56.99 billion in 2023, expected to reach USD 62.68 billion in 2024, and is projected to grow at a CAGR of 10.38%, to USD 113.79 billion by 2030.

The dermatological therapeutics market encompasses a broad spectrum of treatments and products aimed at addressing skin-related health issues, ranging from common conditions like acne and psoriasis to severe diseases such as melanoma. This sector is necessitated by rising skin disorders and a growing awareness of skincare and treatment options, spurred by environmental changes and lifestyle factors. Applications of dermatological therapeutics include topical treatments, systemic medications, and advanced therapies like biologics and gene therapies, catering to medical centers, dermatology clinics, and research institutions as primary end-users. Key growth influencers include increased healthcare spending, advancing technological innovations, and a strong demand for aesthetic enhancement procedures. The rise in personalized medicine and genetic research opens potential opportunities for targeting rare and severe dermatological conditions; investment in this area could yield substantial returns. To seize these opportunities, companies should focus on emerging markets with unmet needs and invest in innovative drug development technologies. However, challenges such as high R&D costs, stringent regulatory environments, and competition from generic products pose limitations. Companies must also navigate patent cliffs and potential side effects associated with novel therapies. The most promising areas for innovation include biologic therapeutics, teledermatology advancements, and artificial intelligence in diagnosis and treatment personalization. The market is dynamic, characterized by high competition and rapid changes prompted by technological advancements and consumer expectations. Research and development focused on multifunctional drugs that combine therapeutic and cosmeceutical benefits represent a growth avenue, aligning with demand for products that cater to both dermatological health and aesthetic desires. Companies looking to stay competitive should also consider strategic collaborations or acquisitions to enhance their portfolios and market reach. By navigating these dynamics thoughtfully, stakeholders in the dermatological therapeutics market can leverage innovation and unmet clinical needs to spur business growth effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 56.99 billion
Estimated Year [2024] USD 62.68 billion
Forecast Year [2030] USD 113.79 billion
CAGR (%) 10.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatological Therapeutics Market

The Dermatological Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalences of the skin disorders
    • Increasing healthcare expenditure and growing awareness about skin diseases
    • Rising demand for homeopathy dermatology therapeutics
  • Market Restraints
    • Relatively high cost of the dermatology therapeutics
  • Market Opportunities
    • Development of next-generation therapeutics for skin cancer
    • Medical dermatology therapeutic R&D and technical innovation
  • Market Challenges
    • Side effects for certain classes of therapeutic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Dermatological Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatological Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatological Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatological Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatological Therapeutics Market

A detailed market share analysis in the Dermatological Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatological Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatological Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatological Therapeutics Market

A strategic analysis of the Dermatological Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatological Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics Inc., Allergan PLC by AbbVie Inc., Almirall, LLC, Amgen Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Galderma Laboratories, L.P., GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Leo Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Dermatological Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across Anti-Acne, Anti-Infectives, Calcineurin Inhibitors, Corticosteroids, and Retinoids.
  • Based on Application, market is studied across Alopecia, Atopic Dermatitis, Herpes, Psoriasis, and Rosacea.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of the skin disorders
      • 5.1.1.2. Increasing healthcare expenditure and growing awareness about skin diseases
      • 5.1.1.3. Rising demand for homeopathy dermatology therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the dermatology therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of next-generation therapeutics for skin cancer
      • 5.1.3.2. Medical dermatology therapeutic R&D and technical innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects for certain classes of therapeutic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermatological Therapeutics Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Anti-Acne
  • 6.3. Anti-Infectives
  • 6.4. Calcineurin Inhibitors
  • 6.5. Corticosteroids
  • 6.6. Retinoids

7. Dermatological Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Alopecia
  • 7.3. Atopic Dermatitis
  • 7.4. Herpes
  • 7.5. Psoriasis
  • 7.6. Rosacea

8. Americas Dermatological Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dermatological Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dermatological Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aclaris Therapeutics Inc.
  • 2. Allergan PLC by AbbVie Inc.
  • 3. Almirall, LLC
  • 4. Amgen Inc.
  • 5. AstraZeneca PLC
  • 6. Bausch Health Companies Inc.
  • 7. Bristol-Myers Squibb Company
  • 8. Eli Lilly and Company
  • 9. Galderma Laboratories, L.P.
  • 10. GlaxoSmithKline PLC
  • 11. Johnson & Johnson Services Inc.
  • 12. Leo Pharma A/S
  • 13. Merck & Co., Inc.
  • 14. Novartis AG
  • 15. Pfizer Inc.
  • 16. Sun Pharmaceutical Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DERMATOLOGICAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMATOLOGICAL THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-ACNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023